Recruiting Narcolepsy Type 1 Studies in Atlanta
About Narcolepsy Type 1 Clinical Trials in Atlanta
Narcolepsy type 1 is characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy), caused by loss of hypocretin-producing neurons in the brain. It affects about 1 in 2,000 people. Treatment includes stimulants, sodium oxybate, and newer orexin receptor agonists.
There are currently 3 narcolepsy type 1 clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 462 participants. Research is being sponsored by Centessa Pharmaceuticals (UK) Limited, Alkermes, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Type 1 Clinical Trials in Atlanta — FAQ
Are there narcolepsy type 1 clinical trials in Atlanta?
Yes, there are 3 narcolepsy type 1 clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Atlanta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.
Are clinical trials in Atlanta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.
What narcolepsy type 1 treatments are being tested?
The 3 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy type 1.
Data updated October 15, 2026 from ClinicalTrials.gov